Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. - Wikidata - awgldk - TriplyDB

Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States.

Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States.

http://www.wikidata.org/entity/Q44062771

about

CHKA and PCYT1A gene polymorphisms, choline intake and spina bifida risk in a California population Fortification of wheat and maize flour with folic acid for population health outcomes Neural tube defects and folate: case far from closed Metal contamination and the epidemic of congenital birth defects in Iraqi cities Prevalence of severe congenital heart disease after folic acid fortification of grain products: time trend analysis in Quebec, Canada Fetal surgery for neural tube defects Born too soon: care before and between pregnancy to prevent preterm births: from evidence to action Prevention of neural-tube defects with periconceptional folic acid, methylfolate, or multivitamins?Preconception care: nutritional risks and interventions Novel Mode of Defective Neural Tube Closure in the Non-Obese Diabetic (NOD) Mouse Strain Contemporary issues surrounding folic Acid fortification initiatives Folate deficiency and folic acid supplementation: the prevention of neural-tube defects and congenital heart defects A genetic signature of spina bifida risk from pathway-informed comprehensive gene-variant analysis Study of the association between the incidences of congenital anomalies and hydrocephalus in Sudanese fetuses.Emerging treatments for retinopathy of prematurity Changing lifestyles and oral clefts occurrence in Denmark.Genetic and lifestyle variables associated with homocysteine concentrations and the distribution of folate derivatives in healthy premenopausal women.Folic acid to reduce neonatal mortality from neural tube disorders.The effect of folic acid, protein energy and multiple micronutrient supplements in pregnancy on stillbirths Primary prevention of neural-tube defects and some other congenital abnormalities by folic acid and multivitamins: history, missed opportunity and tasks.Population red blood cell folate concentrations for prevention of neural tube defects: Bayesian model.Periconceptional nutrient intakes and risks of neural tube defects in California Neural tube defects and maternal biomarkers of folate, homocysteine, and glutathione metabolism.Folate Metabolism and Human Reproduction.Folic acid in early pregnancy: a public health success story Impact of folic acid fortification of flour on neural tube defects: a systematic review.Maternal obesity, folate intake, and neural tube defects in offspring.Transcriptome profiling of genes involved in neural tube closure during human embryonic development using long serial analysis of gene expression (long-SAGE).Association of folate receptor (FOLR1, FOLR2, FOLR3) and reduced folate carrier (SLC19A1) genes with meningomyelocele.Challenges and new opportunities for clinical nutrition interventions in the aged Neural tube defects and maternal folate intake among pregnancies conceived after folic acid fortification in the United States.The impact of spina bifida on caregivers.Folic acid supplementation in early pregnancy and asthma in children aged 6 years.The National Center on Birth Defects and Developmental Disabilities: past, present, and future.Maternal consumption of non-staple food in the first trimester and risk of neural tube defects in offspring.Folate status of reproductive age women and neural tube defect risk: the effect of long-term folic acid supplementation at doses of 140 µg and 400 µg per day.Folic acid food fortification-its history, effect, concerns, and future directions Hospital use, associated costs, and payer status for infants born with spina bifida Gene-environment interactions: a review of effects on reproduction and development.Childhood cancer incidence trends in association with US folic acid fortification (1986-2008)

P2860

Q21245277-AFD54ECF-E04E-4F07-9FBF-F0AF9D2C35A6 Q24185965-9D718270-4876-4E63-B4C0-4D64CB5F1893 Q24617456-690A22D7-46F4-4937-BB4F-E638613B0BE2 Q24631199-CDFAD7B1-1384-4C8E-AEE7-C002FE80D4C8 Q24644292-38915177-AF44-4FF8-9ECD-C4E72AB6859F Q24655093-73ED1FED-46C4-4854-AB51-B2AB83A1352F Q26865543-1B4BA588-04C1-4D3D-AF2B-2A9998C664AF Q27001700-40F6CC76-EADE-4139-9FC1-ED8F76064011 Q27022466-D41767D1-B284-4607-881B-BF338ED83B01 Q27305394-3E69DB50-5679-4257-A180-3525339EF45C Q28083544-53CB6417-4762-4F16-98C7-AEDE6BDD793C Q28302935-7F96E652-DC60-4C1F-B646-089D46FF8903 Q28742080-C3802AAF-2110-454B-8582-67A192B914F7 Q30385425-F65155DC-30A1-4743-8B8D-6515F1631E69 Q33431318-0C126A9A-FB5B-4585-B453-45066DF9728D Q33705978-D89E5EC1-A776-4CF6-BA3A-32D434CE688C Q33732467-2BA14E40-9AEF-4061-A972-5FDC6CD10CD6 Q33754493-05E98D70-8600-409B-9A4D-3D9970FB5C3E Q33875758-63DE7401-E648-4B2D-8C4F-B1A3987BFE39 Q33949484-25003058-F554-4621-AAA3-DF052557DE2E Q33969910-CB252961-A870-4A73-8B81-FE4FDB251F43 Q34091191-249DF8B5-95BE-46F2-AEF0-1759D9906F10 Q34240297-6E287EF6-3F80-47EC-81F2-159CE737A372 Q34243897-B7FB04F5-42FC-4449-986B-E0D3DB8EA78F Q34281640-0A8C0765-7D29-4F10-B7C4-10656BA94AC9 Q34291579-F79DA240-943A-4A90-A449-9ECC5AA85C20 Q34327550-BEFE67CA-27E2-4E4C-9DCD-C242E106E340 Q34341021-641A4CD9-E942-4CE6-B1B1-43E3B6CE9BA4 Q34614130-E0307737-46A7-4AB6-B58A-82E405FC6E56 Q35110793-EAD03C02-28CF-40C4-B661-EBA6961A2C1E Q35116653-4E4643A3-E930-4181-97F2-930DC5A5A39D Q35309398-2B006382-3A5F-45D9-B7E7-E2F25DACC715 Q35634260-13130523-8716-4277-BADB-2E033EDEE5F8 Q35653556-C4463956-77F8-4819-BE6B-99C03C5339C5 Q35657988-BBA2E6A9-2E5C-4934-8730-8B74B681F82E Q35671164-5A83576A-5C83-4EE4-A9E1-E375585FA387 Q35671211-69448B33-B008-47FE-8B4B-4B8825B48408 Q35866246-48233498-4BBA-472E-97A9-5958A857CAC0 Q35989056-BAE85543-E827-4B5D-BD38-3F5F191D69CD Q35996802-E8313950-5ECD-40B3-A7E9-AB42B4B84729

P2860

Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States.

http://www.wikidata.org/entity/Q44062771

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh

2002年學術文章

@zh-hant

name

Prevalence of spina bifida and ...... fication in the United States.

@en

Prevalence of spina bifida and ...... fication in the United States.

@nl

type

label

Prevalence of spina bifida and ...... fication in the United States.

@en

Prevalence of spina bifida and ...... fication in the United States.

@nl

prefLabel

Prevalence of spina bifida and ...... fication in the United States.

@en

Prevalence of spina bifida and ...... fication in the United States.

@nl

P1433

Q44062771-5932FAFF-2A27-45BC-962D-939E7C2281BE

P1476

Q44062771-CC115638-D897-443A-8C1E-B78550125930

P2093

Q44062771-3E311ED7-3F9E-4F96-817D-FBC4AD613417

Q44062771-58A4B950-FC9D-49B5-98EA-CBE86C22A754

Q44062771-5A3F2EE5-797C-4637-BFAB-5E33BD675F2A

Q44062771-665FBBAB-AE22-4FD9-BD53-20CED43D7A5F

Q44062771-84F114EE-7BA6-4689-A505-7203E706EB28

Q44062771-873F2E19-9950-4A3D-93E7-4BB4F893CBC0

Q44062771-A7A079EB-EF34-4B72-98C8-D8AA8D272D25

Q44062771-FC7239B8-0486-46DB-A898-A7AE78484D4D

Q44062771-FD478343-BBA2-4095-8B33-1B062FC8B858

P304

Q44062771-CDCB9EF9-FD54-4293-AAF9-91B8B18C934C

P31

Q44062771-104EFEA1-E127-49DC-9AA5-D8FC2C85A6F9

P356

Q44062771-E26F242E-F87B-4D5B-84C8-3602CEDB75E8

P433

Q44062771-C689358A-93F1-4F88-987B-E16C704D1A8B

P478

Q44062771-44A18ADD-AA8B-4A1D-9332-EF152E516D05

P50

Q44062771-C82B140C-A0E1-46C1-B61A-7B7655B237DD

P577

Q44062771-83A2B411-FE52-45E4-8E29-8F1F7C4DFB0D

P698

Q44062771-445F5B4C-B15A-4974-9D71-C6E0B6B19232

P921

Q44062771-B7E132EC-D25F-47D4-B946-E8390E470C24

P356

P1433

Birth Defects Research Part A: Clinical and Molecular Teratology

P1476

Prevalence of spina bifida and ...... fication in the United States.

@en

P2093

Cara T Mai

http://www.w3.org/2001/XMLSchema#string

Charlotte A Hobbs

http://www.w3.org/2001/XMLSchema#string

F John Meaney

http://www.w3.org/2001/XMLSchema#string

Larry D Edmonds

http://www.w3.org/2001/XMLSchema#string

Laura J Williams

http://www.w3.org/2001/XMLSchema#string

Lisa A Miller

http://www.w3.org/2001/XMLSchema#string

Lowell E Sever

http://www.w3.org/2001/XMLSchema#string

Miriam Levitt

http://www.w3.org/2001/XMLSchema#string

Russell S Kirby

http://www.w3.org/2001/XMLSchema#string

P304

33-39

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/TERA.10060

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P50

P577

2002-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12115778

http://www.w3.org/2001/XMLSchema#string

P921